The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice

Nature Medicine

Volumn 4, Issue 9, 1998, Pages 1065-1067

  Moriya, Kyoji ^a   Fujie, Hajime ^a   Shintani, Yoshizumi ^a   Yotsuyanagi, Hiroshi ^a   Tsutsumi, Takeya ^a   Ishibashi, Kotaro ^b   Matsuuras, Yoshiharu ^c   Kimura, Satoshi ^a   Miyamura, Tatsuo ^c   Koike, Kazuhiko ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b Daiichi Pharmaceuticals   (Japan)

^c NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CORE PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CELL DEATH; CELL PROLIFERATION; CONTROLLED STUDY; ELECTRON MICROSCOPY; HEPATITIS C; HEPATITIS C VIRUS; HISTOPATHOLOGY; IMMUNOBLOTTING; LIVER CELL CARCINOMA; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL TRANSFORMATION, VIRAL; FEMALE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; LIVER NEOPLASMS; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; VIRAL CORE PROTEINS;

ANIMALIA; DNA VIRUSES; HEPATITIS C VIRUS; MUS MUSCULUS;

EID: 0031712813     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/2053     Document Type: Article

References (23)

1. Saito, I. et al. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc. Natl. Acad. Sci. USA 87, 6547-6549 (1990).
2. Simonetti, R.G. et al. Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. Ann. Intern. Med. 116, 97-102 (1992).
3. Ray R.B., Lagging, L.M. Meyer, K. & Ray, R. Hepatitis C virus core protein cooperates ras and transforms primary rat embryo fibroblasts to tumorigenic phenotype. J. Virol. 70, 4438-4443 (1996).
4. Chang, J. et al. Hepatitis C virus core from two different genotypes has an oncogenic potential but is not sufficient for transforming primary rat embryo fibroblasts in cooperation with the H-ras oncogene. J. Virol. 72, 3060-3065 (1998).
5. Kim, D.W., Suzuki, R., Harada, T., Saito, I. & Miyamura, T. Trans-suppression of gene expression by hepatitis C viral core protein. Jpn. J. Med. Sci. Biol. 47, 211-220 (1994).
6. Ray, R.B., Steele, R., Meyer, K. & Ray, R. Transcriptional repression of p53 promoter by hepatitis C virus core protein. J. Biol. Chem. 272, 10983-10986 (1997).
7. Ruggieri, A., Harada, T., Matsuura, Y. & Miyamura, T. Sensitization to Fas-mediated apoptosis by hepatitis C virus core protein. Virology 229, 68-76 (1997).
8. Ray, R.B., Meyer, K. & Ray, R. Suppression of apoptotic cell death by hepatitis C virus core protein. Virology 226, 176-182 (1996).
9. Moriya, K. et al. Hepatitis C virus core protein induces hepatic steatosis in transgenic mice. J. Gen. Virol. 78, 1527-1531 (1997).
10. Sugihara, S. et al. The morphologic transition in hepatocellular carcinoma. Gastroenterology 70, 1488-1492 (1992).
11. Nakashima, O., Sugihara, S., Kage, M. & Kojiro, M. Pathomorphologic characteristics of small hepatocellular carcinoma: a special reference to small hepatocellular carcinoma with distinct margins. Hepatology 22, 101-105 (1995).
12. Hino, O. & Kajino, K. Hepatitis virus-related hepatocarcinogenesis. Intervirology 37, 133-135 (1994).
13. Bach, N., Thung, S.N. & Schaffner F. The histological features of chronic hepatitis C and autoimmune chronic hepatitis: a comparative analysis. Hepatology 15, 572-577 (1992).
14. Frith, C.H. & Ward, J.M. A morphological classification of proliferative and neoplastic hepatic lesions in mice. J. Environ. Pathol. Toxicol. 3, 329-351 (1979).
15. Smith, G.S., Walford, R.L. & Mickey, M.R. Lifespan and incidence of cancer and other diseases in selected long-lived inbred mice and their F1 hybrids. J. Natl. Cancer Inst. 50, 1195-1213 (1973).
16. Nakamura, K., Kuramoto, K., Shibasaki, K., Sumiya, S. & Ohtsubo, K. Age-related incidence of spontaneous tumors in SPF C57BL/6 and BDF1 mice. Exp. Anim. 41, 279-285 (1992).
17. Caporaso, N. et al. Hepatitis C virus infection is an additive risk factor for development of hepatocellular carcinoma in patients with cirrhosis. J. Hepatol. 12, 367-371 (1991).
18. Koike, K. et al. Sialadenitis resembling Sjogren's syndrome in hepatitis C virus envelope gene transgenic mice. Proc. Natl. Acad. Sci. USA 94, 233-236 (1997).
19. Kawamura, T. et al. Transgenic expression of hepatitis C virus structural proteins in the mice. Hepatology 25, 1014-1021 (1997).
20. Matsuda, J. et al. Transgenic mouse expressing a full-length hepatitis C virus cDNA. Jpn. J. Cancer Res. 89, 150-158 (1998).
21. Pasquinelli, C. et al. Hepatitis C virus core and E2 protein expression in transgenic mice. Hepatology 25, 719-727 (1997).
22. Moriya, K. et al. Subcellular localization of hepatitis C virus structural proteins in the liver of transgenic mice. Jpn. J. Med. Sci. Biol. 50, 169-177 (1997).
23. Paradis, V. et al. In situ detection of lipid peroxidation in chronic hepatitis C: correlation with pathological features. J. Clin. Pathol. 50, 401-406 (1997).